Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of <i>Clostridium difficile</i> Infection Associated with Antibacterial Drug Exposure

Antibacterial drug exposure (ADE) is a well-known potential risk factor for <i>Clostridium difficile</i> infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI risk associated with ADE, we reviewed the...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing Liu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2023-06-01
Rangatū:	Antibiotics
Ngā marau:	<i>Clostridium difficile</i> infection antibacterial drug FDA Adverse Event Reporting System pharmacovigilance disproportionality analysis adverse reaction
Urunga tuihono:	https://www.mdpi.com/2079-6382/12/7/1109
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!